Walk before you run: Feasibility challenges and lessons learned from the PROCLAIM study, a multicenter randomized controlled trial of misoprostol for prevention of recurrent Clostridioides difficile during COVID-19

MLA

Robert R. Lavieri, et al. “Walk before You Run: Feasibility Challenges and Lessons Learned from the PROCLAIM Study, a Multicenter Randomized Controlled Trial of Misoprostol for Prevention of Recurrent Clostridioides Difficile during COVID-19.” Anaerobe, vol. 80, Apr. 2023, p. 102699. EBSCOhost, https://doi.org/10.1016/j.anaerobe.2023.102699.

APA

Robert R. Lavieri, Erik R. Dubberke, Sarah K. McGill, Luther Bartelt, Stephanie A. Smith, Balint K. Pandur, Sharon E. Phillips, Krista Vermillion, Jana Shirey-Rice, Jill Pulley, Yaomin Xu, Christopher J. Lindsell, Nicole Zaleski, Rebecca Jerome, Ryan S. Doster, & David M. Aronoff. (2023). Walk before you run: Feasibility challenges and lessons learned from the PROCLAIM study, a multicenter randomized controlled trial of misoprostol for prevention of recurrent Clostridioides difficile during COVID-19. Anaerobe, 80, 102699. https://doi.org/10.1016/j.anaerobe.2023.102699

Chicago

Robert R. Lavieri, Erik R. Dubberke, Sarah K. McGill, Luther Bartelt, Stephanie A. Smith, Balint K. Pandur, Sharon E. Phillips, et al. 2023. “Walk before You Run: Feasibility Challenges and Lessons Learned from the PROCLAIM Study, a Multicenter Randomized Controlled Trial of Misoprostol for Prevention of Recurrent Clostridioides Difficile during COVID-19.” Anaerobe 80 (April): 102699. doi:10.1016/j.anaerobe.2023.102699.